Tumor necrosis factor alpha and high sensitivity C-reactive protein in diagnosis of exudative pleural effusion
- PMID: 22973340
- PMCID: PMC3430056
Tumor necrosis factor alpha and high sensitivity C-reactive protein in diagnosis of exudative pleural effusion
Abstract
Background: Differentiation between exudative and transudative pleural effusions is the initial step in assessment of pleural effusion. The aim of this study was to determine whether high sensitivity C-reactive protein (hsCRP) and tumor necrosis factor α (TNFα) are diagnostic utilities for exudative pleural effusion.
Methods: This experimental study assessed 79 patients with pleural effusion who underwent diagnostic evaluations at Imam Reza hospital, Mashhad, Iran in 2009-2010. The complete biochemical analysis of pleural fluid, pleural fluid culture, and pathological examination of pleural fluid and tissue were performed. Moreover, hsCRP and TNFα concentrations were measured in pleural fluid samples. The data was analyzed by student's t-test and Mann-Whitney test.
Results: According to Light's criteria, 50 patients (63.30%) had exudative effusions while 29 subjects (36.70%) had transudative effusion. The pleural fluid concentrations of hsCRP and TNFα were significantly higher in the exudative group than the transudative group (p < 0.05). At a cutoff value of 5 mg/L for hsCRP, the results showed 94% sensitivity and 96.6% specificity. Regarding TNFα, a cutoff value of 12.9 ng/dl represented 96% sensitivity and 93% specificity.
Conclusions: HsCRP and TNFα levels may be considered as beneficial diagnostic factors for detecting exudative effusion in patients with pleural effusion.
Keywords: Exudative; HsCRP; Pleural Effusion; TNFα; Transudative.
Conflict of interest statement
Similar articles
-
Role of CRP as a marker for discrimination of exudative and transudative pleural effusion.Monaldi Arch Chest Dis. 2022 Mar 14;92(4). doi: 10.4081/monaldi.2022.2059. Monaldi Arch Chest Dis. 2022. PMID: 35293196
-
Diagnostic Accuracy of Drop Hydrogen Peroxide Test as a Novel Bedside Diagnostic Test to Differentiate Transudative and Exudative Pleural Effusion Against Light's Criteria.Kathmandu Univ Med J (KUMJ). 2022 Jan-Mar;20(77):93-96. Kathmandu Univ Med J (KUMJ). 2022. PMID: 36273299
-
Diagnostic value of pleural cholesterol in differentiating exudative and transudative pleural effusion.Ann Med Surg (Lond). 2022 Sep 5;82:104479. doi: 10.1016/j.amsu.2022.104479. eCollection 2022 Oct. Ann Med Surg (Lond). 2022. PMID: 36268319 Free PMC article.
-
Pleural diseases.Dis Mon. 1992 May;38(5):266-331. doi: 10.1016/0011-5029(92)90007-c. Dis Mon. 1992. PMID: 1572232 Review.
-
Diagnostic approach to pleural effusion in adults.Am Fam Physician. 2006 Apr 1;73(7):1211-20. Am Fam Physician. 2006. PMID: 16623208 Review.
Cited by
-
Diagnostic accuracy of pleural fluid tumor necrosis factor-α in tuberculous pleurisy: A meta-analysis.J Res Med Sci. 2015 Jul;20(7):701-6. doi: 10.4103/1735-1995.166230. J Res Med Sci. 2015. PMID: 26622262 Free PMC article. Review.
-
Role of C-Reactive Protein in Discrimination between Transudative and Exudative Pleural Effusions.Diagnostics (Basel). 2021 Oct 28;11(11):2003. doi: 10.3390/diagnostics11112003. Diagnostics (Basel). 2021. PMID: 34829350 Free PMC article.
References
-
- Light RW. Clinical practice. Pleural effusion. N Engl J Med. 2002;346(25):1971–7. - PubMed
-
- RezaeiTalab F, Ghasemi J, Akbari H, AhmadiHoseini H. Serum and pleural fluid albumin gradient in diffrentiation of exudate and transudate cuases. Medical Journal of Mashhad University of Medical Sciences. 2007;49(94):343–50.
-
- Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448–54. - PubMed
-
- Kiropoulos TS, Kostikas K, Oikonomidi S, Tsilioni I, Nikoulis D, Germenis A, et al. Acute phase markers for the differentiation of infectious and malignant pleural effusions. Respir Med. 2007;101(5):910–8. - PubMed
-
- Tuberk Toraks. 2004;52(2):122–9. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials